feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Freezing Tumors: A New Hope for Elderly Cancer Patients

Freezing Tumors: A New Hope for Elderly Cancer Patients

23 Jan

•

Summary

  • Cryoablation freezes breast tumors, offering an alternative to surgery.
  • This method suits elderly patients with heart conditions and aggressive cancers.
  • Success rates are high, but long-term outcomes are still under study.
Freezing Tumors: A New Hope for Elderly Cancer Patients

Cryoablation, a groundbreaking therapy that freezes breast tumors, is providing a crucial alternative for elderly patients facing aggressive cancers and other co-morbidities. This minimally invasive procedure is emerging as a viable option for individuals deemed too high-risk for conventional surgery.

For patients like Chanderkala Lohani, 78, who was diagnosed with triple-negative breast cancer and hypertrophic cardiomyopathy, cryoablation offered a lifeline. Standard treatments such as general anesthesia surgery, chemotherapy, and radiotherapy were contraindicated due to her fragile heart condition and the cardiotoxic nature of some therapies.

During cryoablation, a probe is inserted into the tumor under imaging guidance, and extremely cold temperatures are applied. This creates an ice ball that damages and kills cancer cells, which the body then gradually removes. The procedure is typically performed under local anesthesia, leading to a quicker recovery, minimal pain, and reduced scarring.

trending

UAE weather tomorrow: Temperatures dip

trending

Sixers referees miss call

trending

Song Yadong slams O'Malley

trending

Oklahoma upsets South Carolina

trending

Texas new home sales rebound

trending

Curry attempts 10000th three

trending

Sabalenka defeats Anastasia Potapova

trending

Kawhi Leonard injury update

trending

LeBron James plays Clippers

While surgery remains the primary treatment for breast cancer, cryoablation is suitable for selected early-stage tumors (T1 or T2, under 5 cm) that have not spread. Current research indicates high success rates, with some studies reporting nearly 100% ablation for very small tumors and over 90% for larger ones, comparable to lumpectomy outcomes in similar patient groups. However, it's noted that long-term outcomes are still being evaluated, and the treatment is not yet a standard replacement for surgery.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Cryoablation is a minimally invasive treatment that destroys breast tumors by freezing them, rather than removing them through surgery.
It's suitable for early-stage breast cancers in patients who are medically unfit for surgery due to age or other conditions.
Major trials show high success rates, with nearly 100% ablation for very small tumors and over 90% for tumors up to 2 cm.

Read more news on

Healthside-arrow

You may also like

New Therapy Turns Cancer's Allies Against It

11 Jan • 65 reads

article image

Beyond Lifestyle: Unveiling Genetic Cancer

9 Jan • 73 reads

article image

Cancer Treatment Timing Matters: Early Doses Boost Survival

23 Dec, 2025 • 138 reads

article image

Hina Khan's Brave Battle With Stage 3 Breast Cancer

13 Dec, 2025 • 180 reads

article image

New TNBC Vaccine Shows Promise, Triggers Immune Response

12 Dec, 2025 • 228 reads